8-K
Current Report
Foghorn Therapeutics Inc. Filed Acc 0001628280-24-052539
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading fhtx-20241229.htm…